Proteomics in melanoma biomarker discovery: great potential, many obstacles. - Wikidata - awgldk - TriplyDB

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

http://www.wikidata.org/entity/Q35374035

about

Performance reproducibility index for classification A protein deep sequencing evaluation of metastatic melanoma tissues Protein target quantification decision tree.Biomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges.Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.Proteomic Findings in Melanoma.A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma.MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles.

P2860

Q24289201-99E13668-0BFE-4DF5-87D9-065E31E6E59F Q28546229-1246879E-F2E0-4501-B861-0B57EAFAC039 Q36582456-55BDF6E3-6344-41CD-AF81-C7E83DF7B5A6 Q36758011-2F5A8D4C-3941-43C8-818C-5E6A76952265 Q36893247-F22CF14F-1736-4D3B-9CBB-D485B1C12A3B Q36956140-CF07D44B-3B24-494F-8347-FC1FB4197B53 Q37214957-D9D8CF1A-F23A-4673-A2DE-1220747EFD08 Q37384738-F6757BC3-89C1-4769-B8AD-2130FFDFB3F4 Q41860469-39DCCA17-9EDD-4769-BD23-B670B1207223 Q47127034-E8FC94B5-37EA-4D71-8B9E-489C40BCD510

P2860

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

http://www.wikidata.org/entity/Q35374035

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@ast

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@en

type

label

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@ast

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@en

prefLabel

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@ast

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@en

P1433

Q35374035-42A6235C-AA69-4694-991D-C0116A6C0701

P1476

Q35374035-4D6EF73B-CE65-4D56-AFAE-8065D5F0D545

P2093

Q35374035-9DAE2A11-CE78-4B6F-864F-F6E779DBFE51

Q35374035-A3373E03-EBAE-41B3-B86A-1F82E5779912

Q35374035-DED6BF57-2FF7-4E96-A3AF-5F14C36A2F27

P2860

Q35374035-03116BC0-A1EA-4693-AFF0-B66C2CBBFA4A

Q35374035-0AE0F596-91D2-4A49-A093-CBC423C54F57

Q35374035-22BDBCEA-305E-4EA2-8F77-002D56AF628A

Q35374035-27018A72-B4ED-4DB4-8A96-3D5E6E52F0E2

Q35374035-2D0118D8-F7B2-4033-9FB9-05999F71F2BD

Q35374035-2E79A27F-DB4F-49AE-B5DC-62E26CB57A1B

Q35374035-391C9AF0-4BBD-4C23-AE14-19F71D86CDBF

Q35374035-41EF4D03-301F-4B63-9A1F-B7EB166B01E3

Q35374035-46D14145-075C-4754-B23E-538397A469C8

Q35374035-58C442D9-3E24-4FD1-92A5-46311A895F07

P304

Q35374035-B9DFF423-5329-469D-95B4-29F2A853547F

P31

Q35374035-9208F4B2-C0C0-4093-B631-A82D58370A25

P356

Q35374035-D1A65348-02C8-4028-9AE3-4D6D6B9697EE

P478

Q35374035-301F110C-8D79-4A3B-83F7-982CA881AEE5

P577

Q35374035-BF3868FA-0097-418F-A31F-A0E9629D3E32

P5875

Q35374035-0944FA29-B850-4EC3-AB46-89FE0C98A937

P698

Q35374035-04597A3E-816D-4961-ABAF-2F1C2E4C7684

P921

Q35374035-30448661-41FE-4256-BB27-BAFC54163C17

P932

Q35374035-1E0C98C2-C4FF-4E35-ACE7-96A186534C1A

P356

P1433

International Journal of Proteomics

P1476

Proteomics in melanoma biomarker discovery: great potential, many obstacles.

@en

P2093

David M Lubman

http://www.w3.org/2001/XMLSchema#string

Michael S Sabel

http://www.w3.org/2001/XMLSchema#string

Yashu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Final version of 2009 AJCC melanoma staging and classification

Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues.

Study of the development of chemoresistance in melanoma cell lines using proteome analysis.

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.

Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry.

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.

Proteomic analysis of formalin-fixed prostate cancer tissue.

Development of efficient protein extraction methods for shotgun proteome analysis of formalin-fixed tissues.

P304

181890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/181890

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51799494

http://www.w3.org/2001/XMLSchema#string

P698

22084682

http://www.w3.org/2001/XMLSchema#string

P921

P932

3195774

http://www.w3.org/2001/XMLSchema#string